what was glp 1 originally used for History of glucagon-like peptide-1 receptor agonists What is GLP-1 – CSB

One of the consequences is the potential to trigger or worsen SIBO (small intestinal bacterial overgrowth)

In a Phase 2 clinical trial involving adults with obesity, participants receiving the highest dose achieved an average weight reduction approaching 24% at 48 weeks , among the largest weight losses reported with a medication

Side Effects to Know About The most common side effects are digestive: Nausea & Vomiting Diarrhea or constipation Bloating These often improve after the first few weeks as your body adjusts

For oral semaglutide (Rybelsus) , timing matters

[DOI] [PMC free article] [PubMed] [Google Scholar] 199.Dantas Machado A.C., Brown S.D., Lingaraju A., Sivaganesh V., Martino C., Chaix A., Zhao P., Pinto A.F.M., Chang M.W., Richter R.A., et al

There are over 100 clinical studies in the pipeline right now